Embolization Devices Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Application, End User, and Geography

Description

List of Tables

According to our new research study on "Embolization Devices Market Forecast to 2031 -Global Analysis - by Product, Lead Type, Technology, End User," the market is anticipated to grow from US$ 3.07 billion in 2024 and is projected to reach US$ 5.89 billion by 2031; it is expected to register a CAGR of 9.9% from 2025 to 2031. The embolization devices market growth is attributed to the rising prevalence of clinical conditions and burgeoning demand for minimally invasive techniques.

Embolization devices are medical tools used in a minimally invasive procedure wherein targeted blood vessels are intentionally blocked to control or stop blood flow. This technique is employed to treat conditions such as aneurysms, arteriovenous malformations (AVMs), tumors, and bleeding.

The embolization devices market in North America is segmented into the US, Canada, and Mexico. The embolization devices market in North America is driven by the region's advanced healthcare infrastructure, increasing prevalence of vascular diseases, and growing adoption of minimally invasive procedures. Technological advancements have led to a significant enhancement in the precision and safety of embolization techniques, making them a preferred choice for treating conditions such as aneurysms, arteriovenous malformations, and tumors. The high patient awareness about various medical conditions and treatment options, strong healthcare reimbursement systems, and the presence of leading medical device companies contribute to market maturity in North America. Additionally, public health campaigns play a crucial role in promoting embolization procedures. Ongoing research and clinical trials are further expanding the scope of embolization technologies, with a particular focus on biodegradable and drug-eluting embolic agents. While the US leads in terms of adoption and innovation, Canada and Mexico are progressively increasing their market participation through supportive policies and infrastructure development. However, disparities in healthcare access across rural and urban settings remain a challenge. The region continues to attract significant investments and collaborations among hospitals, research institutes, and device manufacturers, ensuring sustained development and innovation in embolization technologies.

In North America, the US holds a significant share of the embolization devices market. In the US, the embolization devices market is characterized by a high level of innovation, early adoption of emerging technologies, and a strong clinical focus on minimally invasive treatments. As per the study "Minimally Invasive Surgery in the United States, 2022: Understanding Its Value Using New Datasets," the US exhibited a surging trend of minimally invasive surgeries (MIS), including robotic-assisted procedures, across both inpatient and ambulatory settings from 2016 to 2018.

According to the National Cancer Institute, HCC is the most prevalent type of liver cancer in the US, accounting for over 80% of all cases. Healthcare providers increasingly favor embolization procedures for treating conditions such as HCC, uterine fibroids, and brain aneurysms, given their lower risk profiles and quicker recovery times compared to traditional surgeries. The embolization devices market in the US also benefits from substantial investments made in medical technology and robust clinical research supporting the efficacy and safety of embolization therapies. The study titled "Results from a United States Investigational Device Study of Adhesive Capsulitis Embolization in the Treatment of Shoulder Pain," conducted at Prostate Centers USA and published in February 2022, aimed to assess the safety and efficacy of arterial embolization for treating shoulder pain caused by adhesive capsulitis (AC). The findings demonstrated that adhesive capsulitis embolization (ACE) significantly reduced pain and improved shoulder function in patients who were irresponsive to conservative treatments. The study also highlighted statistically significant improvements in VAS (Visual Analog Scale) and SANE (Single Assessment Numeric Evaluation) scores after one-month post-procedure, with these benefits persisting through the six-month follow-up. Additionally, no major adverse events were reported, whereas minor adverse events subsided on their own without the need for intervention.

Growing awareness among both patients and physicians regarding interventional radiology options contributes to the rising utilization of embolization techniques. The presence of major players such as Medtronic, Boston Scientific, and Stryker ensure continuous innovation and competition, keeping the market dynamic and progressive. Academic and medical institutions collaborate frequently with manufacturers to develop and evaluate new devices. In addition, the regulatory framework, although rigorous, supports a structured path of product approval.

Transforming Embolization Through Clinical Innovation to Provide Market Opportunities in Future

Innovations such as improved catheter designs, new embolic agents, and detachable coils have enhanced the efficacy and safety of embolization procedures. For example, the development of flow-diverting devices has revolutionized the treatment of complex intracranial aneurysms by redirecting blood flow away from the aneurysm sac, promoting thrombosis within the aneurysm.

Clinical studies are pivotal in advancing embolization techniques, leading to broader indications and improved patient outcomes. For instance, the IMPASS embolic coil device developed by Fluidx Medical Technology has shown promise in treating chronic subdural hematomas by embolizing the middle meningeal artery (MMA) in January 2023, as demonstrated in in-vivo studies. The Fluidx embolic platform is expected to bring simple preparation and controllable material delivery to various applications. The US FDA granted Investigational Device Exemption (IDE) approval to Fluidx Medical Technology to begin a pivotal clinical trial of the GPX embolic device in May 2024; the trial is designed to assess the safety and effectiveness of the device. Results from the study were recently published in the Journal of Vascular and Interventional Radiology, showing 100% technical success and high physician ratings for ease of preparation, deliverability, and visibility.

In July 2024, MicroVention published the CLEVER study, evaluating the WEB 17 Aneurysm Embolization System in treating both ruptured and unruptured intracranial aneurysms. This multicenter prospective study involved 163 patients across 17 European centers to understand the safety and effectiveness of the newest and smallest WEB system. The results indicate that the WEB 17 system is as safe and effective as previous generations, with low complication rates and no rebleeding incidents at 30 days and for one year post-treatment. Such studies are instrumental in refining device efficacy and expanding the therapeutic scope of embolization devices.

With the numerous applications for peripheral vascular embolization and the wide range of vessel sizes to be treated, no single agent or device fits all indications. The article titled "Results from the First-in-Human Study of the Caterpillar Arterial Embolization System," published in November 2022, assessed occlusion success and events associated with the use of a self-expanding device for peripheral artery embolization. The study was based on clinical outcomes of the Caterpillar Arterial Embolization Device, which features opposing nitinol fibers and a flow-occluding membrane. The device is designed for use in a broad range of arteries, aiming to reduce the number of devices required to achieve effective occlusion. In this first-in-human trial, the Caterpillar device was successfully deployed to embolize peripheral arteries. The procedure resulted in periprocedural occlusion in all participants and demonstrated a 94.7% rate of freedom from device-related serious adverse events (SAEs) at 30 days. The findings also suggest that the Caterpillar device can be used with minimal risk of SAEs related to the device or procedure.

As the market continues to evolve, the synergy between clinical research and device innovation will be crucial in addressing the growing demand for effective embolization therapies. Therefore, the integration of clinical studies into the development of embolization devices, fostering significant advancements in the field and leading to expanded treatment options and improved patient outcomes, is emerging as a significant trend in the embolization devices market.

The US Food and Drug Administration, National Cancer Institute, Brain Aneurysm Foundation, and Our World in data are among the primary and secondary sources referred to while preparing the embolization devices market report.

Product Code: TIPRE00008962

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Analyst Market Outlook

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
3.3 Assumptions and Limitations

4. Embolization Devices Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Pricing Analysis
- 4.3.1 Pricing Analysis By Key Brands

5. Embolization Devices Market - Key Market Dynamics

5.1 Embolization Devices Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Rising Prevalence of Clinical Conditions
- 5.2.2 Burgeoning Demand for Minimally Invasive Techniques
5.3 Market Restraints
- 5.3.1 Complications Arising During or After Embolization
5.4 Market Opportunities
- 5.4.1 New Product Developments and Marketing Approvals
5.5 Future Trends
- 5.5.1 Transforming Embolization Through Clinical Innovation
5.6 Impact of Drivers and Restraints:

6. Embolization Devices Market - Global Market Analysis

6.1 Embolization Devices Market Revenue (US$ Million), 2021-2031
6.2 Embolization Devices Market Forecast Analysis

7. Embolization Devices Market Analysis - by Product Type

7.1 Embolization Coils
- 7.1.1 Overview
- 7.1.2 Embolization Coils: Embolization Devices Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Plugs
- 7.2.1 Overview
- 7.2.2 Plugs: Embolization Devices Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Beads
- 7.3.1 Overview
- 7.3.2 Beads: Embolization Devices Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Glues
- 7.4.1 Overview
- 7.4.2 Glues: Embolization Devices Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Others
- 7.5.1 Overview
- 7.5.2 Others: Embolization Devices Market - Revenue and Forecast to 2031 (US$ Million)

8. Embolization Devices Market Analysis - by Application

8.1 Neurology
- 8.1.1 Overview
- 8.1.2 Neurology: Embolization Devices Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Peripheral Vascular Disease
- 8.2.1 Overview
- 8.2.2 Peripheral Vascular Disease: Embolization Devices Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Oncology
- 8.3.1 Overview
- 8.3.2 Oncology: Embolization Devices Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Urology
- 8.4.1 Overview
- 8.4.2 Urology: Embolization Devices Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: Embolization Devices Market - Revenue and Forecast to 2031 (US$ Million)

9. Embolization Devices Market Analysis - by End User

9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: Embolization Devices Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Ambulatory Centers
- 9.2.1 Overview
- 9.2.2 Ambulatory Centers: Embolization Devices Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Others
- 9.3.1 Overview
- 9.3.2 Others: Embolization Devices Market - Revenue and Forecast to 2031 (US$ Million)

10. Embolization Devices Market - Geographical Analysis

10.1 North America
- 10.1.1 North America Embolization Devices Market Overview
- 10.1.2 North America: Embolization Devices Market - Revenue, 2021-2031 (US$ Million)
  - 10.1.2.1 North America: Embolization Devices Market - Revenue and Forecast Analysis - by Product Type
  - 10.1.2.2 North America: Embolization Devices Market - Revenue and Forecast Analysis - by Embolization Coils
  - 10.1.2.3 North America: Embolization Devices Market - Revenue and Forecast Analysis - by Application
  - 10.1.2.4 North America: Embolization Devices Market - Revenue and Forecast Analysis - by End User
- 10.1.3 North America: Embolization Devices Market - Revenue and Forecast Analysis - by Country
  - 10.1.3.1 United States: Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.3.1.1 United States: Embolization Devices Market Breakdown, by Product Type
    - 10.1.3.1.2 United States: Embolization Devices Market Breakdown, by Embolization Coils
    - 10.1.3.1.3 United States: Embolization Devices Market Breakdown, by Application
    - 10.1.3.1.4 United States: Embolization Devices Market Breakdown, by End User
  - 10.1.3.2 Canada: Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.3.2.1 Canada: Embolization Devices Market Breakdown, by Product Type
    - 10.1.3.2.2 Canada: Embolization Devices Market Breakdown, by Embolization Coils
    - 10.1.3.2.3 Canada: Embolization Devices Market Breakdown, by Application
    - 10.1.3.2.4 Canada: Embolization Devices Market Breakdown, by End User
  - 10.1.3.3 Mexico: Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.3.3.1 Mexico: Embolization Devices Market Breakdown, by Product Type
    - 10.1.3.3.2 Mexico: Embolization Devices Market Breakdown, by Embolization Coils
    - 10.1.3.3.3 Mexico: Embolization Devices Market Breakdown, by Application
    - 10.1.3.3.4 Mexico: Embolization Devices Market Breakdown, by End User
10.2 Europe
- 10.2.1 Europe Embolization Devices Market Overview
- 10.2.2 Europe: Embolization Devices Market - Revenue, 2021-2031 (US$ Million)
  - 10.2.2.1 Europe: Embolization Devices Market - Revenue and Forecast Analysis - by Product Type
  - 10.2.2.2 Europe: Embolization Devices Market - Revenue and Forecast Analysis - by Embolization Coils
  - 10.2.2.3 Europe: Embolization Devices Market - Revenue and Forecast Analysis - by Application
  - 10.2.2.4 Europe: Embolization Devices Market - Revenue and Forecast Analysis - by End User
- 10.2.3 Europe: Embolization Devices Market - Revenue and Forecast Analysis - by Country
  - 10.2.3.1 Germany: Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.1.1 Germany: Embolization Devices Market Breakdown, by Product Type
    - 10.2.3.1.2 Germany: Embolization Devices Market Breakdown, by Embolization Coils
    - 10.2.3.1.3 Germany: Embolization Devices Market Breakdown, by Application
    - 10.2.3.1.4 Germany: Embolization Devices Market Breakdown, by End User
  - 10.2.3.2 United Kingdom: Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.2.1 United Kingdom: Embolization Devices Market Breakdown, by Product Type
    - 10.2.3.2.2 United Kingdom: Embolization Devices Market Breakdown, by Embolization Coils
    - 10.2.3.2.3 United Kingdom: Embolization Devices Market Breakdown, by Application
    - 10.2.3.2.4 United Kingdom: Embolization Devices Market Breakdown, by End User
  - 10.2.3.3 France: Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.3.1 France: Embolization Devices Market Breakdown, by Product Type
    - 10.2.3.3.2 France: Embolization Devices Market Breakdown, by Embolization Coils
    - 10.2.3.3.3 France: Embolization Devices Market Breakdown, by Application
    - 10.2.3.3.4 France: Embolization Devices Market Breakdown, by End User
  - 10.2.3.4 Italy: Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.4.1 Italy: Embolization Devices Market Breakdown, by Product Type
    - 10.2.3.4.2 Italy: Embolization Devices Market Breakdown, by Embolization Coils
    - 10.2.3.4.3 Italy: Embolization Devices Market Breakdown, by Application
    - 10.2.3.4.4 Italy: Embolization Devices Market Breakdown, by End User
  - 10.2.3.5 Spain: Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.5.1 Spain: Embolization Devices Market Breakdown, by Product Type
    - 10.2.3.5.2 Spain: Embolization Devices Market Breakdown, by Embolization Coils
    - 10.2.3.5.3 Spain: Embolization Devices Market Breakdown, by Application
    - 10.2.3.5.4 Spain: Embolization Devices Market Breakdown, by End User
  - 10.2.3.6 Rest of Europe: Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.6.1 Rest of Europe: Embolization Devices Market Breakdown, by Product Type
    - 10.2.3.6.2 Rest of Europe: Embolization Devices Market Breakdown, by Embolization Coils
    - 10.2.3.6.3 Rest of Europe: Embolization Devices Market Breakdown, by Application
    - 10.2.3.6.4 Rest of Europe: Embolization Devices Market Breakdown, by End User
10.3 Asia Pacific
- 10.3.1 Asia Pacific Embolization Devices Market Overview
- 10.3.2 Asia Pacific: Embolization Devices Market - Revenue, 2021-2031 (US$ Million)
  - 10.3.2.1 Asia Pacific: Embolization Devices Market - Revenue and Forecast Analysis - by Product Type
  - 10.3.2.2 Asia Pacific: Embolization Devices Market - Revenue and Forecast Analysis - by Embolization Coils
  - 10.3.2.3 Asia Pacific: Embolization Devices Market - Revenue and Forecast Analysis - by Application
  - 10.3.2.4 Asia Pacific: Embolization Devices Market - Revenue and Forecast Analysis - by End User
- 10.3.3 Asia Pacific: Embolization Devices Market - Revenue and Forecast Analysis - by Country
  - 10.3.3.1 China: Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.1.1 China: Embolization Devices Market Breakdown, by Product Type
    - 10.3.3.1.2 China: Embolization Devices Market Breakdown, by Embolization Coils
    - 10.3.3.1.3 China: Embolization Devices Market Breakdown, by Application
    - 10.3.3.1.4 China: Embolization Devices Market Breakdown, by End User
  - 10.3.3.2 Japan: Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.2.1 Japan: Embolization Devices Market Breakdown, by Product Type
    - 10.3.3.2.2 Japan: Embolization Devices Market Breakdown, by Embolization Coils
    - 10.3.3.2.3 Japan: Embolization Devices Market Breakdown, by Application
    - 10.3.3.2.4 Japan: Embolization Devices Market Breakdown, by End User
  - 10.3.3.3 India: Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.3.1 India: Embolization Devices Market Breakdown, by Product Type
    - 10.3.3.3.2 India: Embolization Devices Market Breakdown, by Embolization Coils
    - 10.3.3.3.3 India: Embolization Devices Market Breakdown, by Application
    - 10.3.3.3.4 India: Embolization Devices Market Breakdown, by End User
  - 10.3.3.4 Australia: Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.4.1 Australia: Embolization Devices Market Breakdown, by Product Type
    - 10.3.3.4.2 Australia: Embolization Devices Market Breakdown, by Embolization Coils
    - 10.3.3.4.3 Australia: Embolization Devices Market Breakdown, by Application
    - 10.3.3.4.4 Australia: Embolization Devices Market Breakdown, by End User
  - 10.3.3.5 South Korea: Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.5.1 South Korea: Embolization Devices Market Breakdown, by Product Type
    - 10.3.3.5.2 South Korea: Embolization Devices Market Breakdown, by Embolization Coils
    - 10.3.3.5.3 South Korea: Embolization Devices Market Breakdown, by Application
    - 10.3.3.5.4 South Korea: Embolization Devices Market Breakdown, by End User
  - 10.3.3.6 Rest of APAC: Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.6.1 Rest of APAC: Embolization Devices Market Breakdown, by Product Type
    - 10.3.3.6.2 Rest of APAC: Embolization Devices Market Breakdown, by Embolization Coils
    - 10.3.3.6.3 Rest of APAC: Embolization Devices Market Breakdown, by Application
    - 10.3.3.6.4 Rest of APAC: Embolization Devices Market Breakdown, by End User
10.4 Middle East & Africa
- 10.4.1 Middle East & Africa Embolization Devices Market Overview
- 10.4.2 Middle East & Africa: Embolization Devices Market - Revenue, 2021-2031 (US$ Million)
  - 10.4.2.1 Middle East & Africa: Embolization Devices Market - Revenue and Forecast Analysis - by Product Type
  - 10.4.2.2 Middle East & Africa: Embolization Devices Market - Revenue and Forecast Analysis - by Embolization Coils
  - 10.4.2.3 Middle East & Africa: Embolization Devices Market - Revenue and Forecast Analysis - by Application
  - 10.4.2.4 Middle East & Africa: Embolization Devices Market - Revenue and Forecast Analysis - by End User
- 10.4.3 Middle East & Africa: Embolization Devices Market - Revenue and Forecast Analysis - by Country
  - 10.4.3.1 Saudi Arabia: Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.3.1.1 Saudi Arabia: Embolization Devices Market Breakdown, by Product Type
    - 10.4.3.1.2 Saudi Arabia: Embolization Devices Market Breakdown, by Embolization Coils
    - 10.4.3.1.3 Saudi Arabia: Embolization Devices Market Breakdown, by Application
    - 10.4.3.1.4 Saudi Arabia: Embolization Devices Market Breakdown, by End User
  - 10.4.3.2 South Africa: Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.3.2.1 South Africa: Embolization Devices Market Breakdown, by Product Type
    - 10.4.3.2.2 South Africa: Embolization Devices Market Breakdown, by Embolization Coils
    - 10.4.3.2.3 South Africa: Embolization Devices Market Breakdown, by Application
    - 10.4.3.2.4 South Africa: Embolization Devices Market Breakdown, by End User
  - 10.4.3.3 United Arab Emirates: Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.3.3.1 United Arab Emirates: Embolization Devices Market Breakdown, by Product Type
    - 10.4.3.3.2 United Arab Emirates: Embolization Devices Market Breakdown, by Embolization Coils
    - 10.4.3.3.3 United Arab Emirates: Embolization Devices Market Breakdown, by Application
    - 10.4.3.3.4 United Arab Emirates: Embolization Devices Market Breakdown, by End User
  - 10.4.3.4 Rest of Middle East & Africa: Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.3.4.1 Rest of Middle East & Africa: Embolization Devices Market Breakdown, by Product Type
    - 10.4.3.4.2 Rest of Middle East & Africa: Embolization Devices Market Breakdown, by Embolization Coils
    - 10.4.3.4.3 Rest of Middle East & Africa: Embolization Devices Market Breakdown, by Application
    - 10.4.3.4.4 Rest of Middle East & Africa: Embolization Devices Market Breakdown, by End User
10.5 South & Central America
- 10.5.1 South & Central America Embolization Devices Market Overview
- 10.5.2 South & Central America: Embolization Devices Market - Revenue, 2021-2031 (US$ Million)
  - 10.5.2.1 South & Central America: Embolization Devices Market - Revenue and Forecast Analysis - by Product Type
  - 10.5.2.2 South & Central America: Embolization Devices Market - Revenue and Forecast Analysis - by Embolization Coils
  - 10.5.2.3 South & Central America: Embolization Devices Market - Revenue and Forecast Analysis - by Application
  - 10.5.2.4 South & Central America: Embolization Devices Market - Revenue and Forecast Analysis - by End User
- 10.5.3 South & Central America: Embolization Devices Market - Revenue and Forecast Analysis - by Country
  - 10.5.3.1 Brazil: Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.5.3.1.1 Brazil: Embolization Devices Market Breakdown, by Product Type
    - 10.5.3.1.2 Brazil: Embolization Devices Market Breakdown, by Embolization Coils
    - 10.5.3.1.3 Brazil: Embolization Devices Market Breakdown, by Application
    - 10.5.3.1.4 Brazil: Embolization Devices Market Breakdown, by End User
  - 10.5.3.2 Argentina: Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.5.3.2.1 Argentina: Embolization Devices Market Breakdown, by Product Type
    - 10.5.3.2.2 Argentina: Embolization Devices Market Breakdown, by Embolization Coils
    - 10.5.3.2.3 Argentina: Embolization Devices Market Breakdown, by Application
    - 10.5.3.2.4 Argentina: Embolization Devices Market Breakdown, by End User
  - 10.5.3.3 Rest of South & Central America: Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.5.3.3.1 Rest of South & Central America: Embolization Devices Market Breakdown, by Product Type
    - 10.5.3.3.2 Rest of South & Central America: Embolization Devices Market Breakdown, by Embolization Coils
    - 10.5.3.3.3 Rest of South & Central America: Embolization Devices Market Breakdown, by Application
    - 10.5.3.3.4 Rest of South & Central America: Embolization Devices Market Breakdown, by End User

11. Competitive Landscape

11.1 Market Concentration by Key Players
11.2 Company Market Share Analysis, 2024

12. Industry Landscape

12.1 Overview
12.2 Expansion
12.3 New Product Development and Approval
12.4 Merger and Acquisition
12.5 Partnerships and Collaboration

13. Company Profiles

13.1 Medtronic Plc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
13.2 Cook Medical Holdings LLC
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
13.3 Stryker Corp
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Boston Scientific Corp
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Terumo Corp
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Johnson & Johnson
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Abbott Laboratories
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
13.8 NeuroSafe Medical Co. Ltd
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
13.9 Wallaby Medical
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Sirtex Medical Ltd
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
13.11 GEM srl
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
13.12 Penumbra Inc.
- 13.12.1 Key Facts
- 13.12.2 Business Description
- 13.12.3 Products and Services
- 13.12.4 Financial Overview
- 13.12.5 SWOT Analysis
13.13 Balt
- 13.13.1 Key Facts
- 13.13.2 Business Description
- 13.13.3 Products and Services
- 13.13.4 Financial Overview
- 13.13.5 SWOT Analysis
- 13.13.6 Key Developments
13.14 Lepu Medical Technology Beijing Co Ltd
- 13.14.1 Key Facts
- 13.14.2 Business Description
- 13.14.3 Products and Services
- 13.14.4 Financial Overview
- 13.14.5 SWOT Analysis
13.15 INVAMED
- 13.15.1 Key Facts
- 13.15.2 Business Description
- 13.15.3 Products and Services
- 13.15.4 Financial Overview
- 13.15.5 SWOT Analysis
13.16 Meril Life Sciences Pvt Ltd
- 13.16.1 Key Facts
- 13.16.2 Business Description
- 13.16.3 Products and Services
- 13.16.4 Financial Overview
- 13.16.5 SWOT Analysis
13.17 Merit Medical Systems Inc
- 13.17.1 Key Facts
- 13.17.2 Business Description
- 13.17.3 Products and Services
- 13.17.4 Financial Overview
- 13.17.5 SWOT Analysis
- 13.17.6 Key Developments
13.18 Lifetech Scientific Corp
- 13.18.1 Key Facts
- 13.18.2 Business Description
- 13.18.3 Products and Services
- 13.18.4 Financial Overview
- 13.18.5 SWOT Analysis

14. Appendix

14.1 About The Insight Partners
14.2 Glossary of Terms